Mon, May 20, 2024
In press (Jan-Feb)
Back to the articles list |
Back to browse issues page
Mohammad Fayaz1 
, Vahid Tajari2 , Mohammad Hosein Taziki Balajelini3 , Abdolhalim Rajabi4 , Seyed Mehran Hosseini 5
, Vahid Tajari2 , Mohammad Hosein Taziki Balajelini3 , Abdolhalim Rajabi4 , Seyed Mehran Hosseini 5
1- Department of Biostatistics, Allameh Tabataba'i University, Tehran, Iran
2- Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran
3- Department of Surgery, School of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan, Iran
4- Environmental Health Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran
5- Department of Physiology, Neuroscience Research Center, School of Medicine, Golestan University of Medical Sciences, Shastkola, Gorgan, Golestan, Iran , hosseini@goums.ac.ir
2- Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran
3- Department of Surgery, School of Medicine, Golestan University of Medical Sciences, Gorgan, Golestan, Iran
4- Environmental Health Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran
5- Department of Physiology, Neuroscience Research Center, School of Medicine, Golestan University of Medical Sciences, Shastkola, Gorgan, Golestan, Iran , hosseini@goums.ac.ir
Abstract: (287 Views)
Background: The outcome of hospitalized COVID-19 patients is predictable according to demographic, clinical, laboratory, and imaging risk factors. We aimed to determine the best outcome predictors and their trends during 30 days of hospitalization.
Methods: This retrospective study was conducted on moderate to severe hospitalized COVID-19 patients from 26 January 2020 to 13 January 2021. The length of stay in the hospital was considered as the time interval between admission and discharge, and the patient's final condition was defined as either dead or alive. Demographic, clinical, and laboratory data were collected from the hospital information system. The generalized additive model and the Cox regression model were used to model data.
Results: Of the 1520 hospitalized COVID-19 patients, 232 (15.26%) died and 1288 survived or reached the end of 30 days of hospitalization. We selected demographic, clinical, and 131 independent laboratory variables. Blood urea nitrogen (BUN) had a nearly double average in the dead group (44.603 [± 25.408] mg/dL) than the survived group (21.304 [± 13.318] mg/dL), and the lymphocyte (Lymph) count showed the opposite trend. The estimated hazard ratio (HR) of these 2 factors was higher than 1 and was statistically significant. In daily stay trends, the hazard function of them also increased rapidly after 15 days.
Conclusion: Blood urea nitrogen and complete blood count provide strong predictive clues about the prognosis of hospitalized COVID-19 patients, and rapid dynamic changes in the second week can predict a poor outcome in these patients.
Methods: This retrospective study was conducted on moderate to severe hospitalized COVID-19 patients from 26 January 2020 to 13 January 2021. The length of stay in the hospital was considered as the time interval between admission and discharge, and the patient's final condition was defined as either dead or alive. Demographic, clinical, and laboratory data were collected from the hospital information system. The generalized additive model and the Cox regression model were used to model data.
Results: Of the 1520 hospitalized COVID-19 patients, 232 (15.26%) died and 1288 survived or reached the end of 30 days of hospitalization. We selected demographic, clinical, and 131 independent laboratory variables. Blood urea nitrogen (BUN) had a nearly double average in the dead group (44.603 [± 25.408] mg/dL) than the survived group (21.304 [± 13.318] mg/dL), and the lymphocyte (Lymph) count showed the opposite trend. The estimated hazard ratio (HR) of these 2 factors was higher than 1 and was statistically significant. In daily stay trends, the hazard function of them also increased rapidly after 15 days.
Conclusion: Blood urea nitrogen and complete blood count provide strong predictive clues about the prognosis of hospitalized COVID-19 patients, and rapid dynamic changes in the second week can predict a poor outcome in these patients.
Research Article: Original Paper |
Subject:
Virology
Received: 2021/12/12 | Accepted: 2022/04/6 | Published: 2024/01/15 | ePublished: 2024/01/15
Received: 2021/12/12 | Accepted: 2022/04/6 | Published: 2024/01/15 | ePublished: 2024/01/15
References
1. Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL. Adult ICU Triage During the Coronavirus Disease 2019 Pandemic: Who Will Live and Who Will Die? Recommendations to Improve Survival. Crit Care Med. 2020;48(8):1196-1202. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Aziz S, Arabi YM, Alhazzani W, Evans L, Citerio G, Fischkoff K, et al. Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med. 2020;46(7):1303-25. [View at Publisher] [DOI:10.1007/s00134-020-06092-5] [PMID] [Google Scholar]
3. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-118. [View at Publisher] [Google Scholar] [DOI] [PMID] [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020;166:108293. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-25. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15(11):e0241955. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights. J Basic Microbiol. 2021;61(3):180-202. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol. 2020; 92(6): 660-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):e1-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):394. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020; 369: m1996. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Gatti M, Calandri M, Biondo A, Geninatti C, Piatti C, Ruggirello I, et al. Emergency room comprehensive assessment of demographic, radiological, laboratory and clinical data of patients with COVID-19: determination of its prognostic value for in-hospital mortality. Intern Emerg Med. 2022;17(1):205-14. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Xu PP, Tian RH, Luo S, Zu ZY, Fan B, Wang XM, et al. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics. 2020;10(14):6372-83. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Alhumaid S, Al Mutair A, Al Alawi Z, Al Salman K, Al Dossary N, Omar A, et al. Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia. Eur J Med Res. 2021;26(1):47. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. SeyedAlinaghi S, Abbasian L, Solduzian M, Ayoobi Yazdi N, Jafari F, Adibimehr A, et al. Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study. Eur J Med Res. 2021;26(1):41. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Bai B, Xu Z, Hu Y, Qu M, Cheng J, Luo S, et al. Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study. Eur J Med Res. 2021;26(1):45. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Leeuwenberg AM, Schuit E. Prediction models for COVID-19 clinical decision making. Lancet Digit Health. 2020;2(10):e496-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Pranata R, Henrina J, Lim MA, Lawrensia S, Yonas E, Vania R, et al. Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis. Arch Gerontol Geriatr. 2021;93:104324. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Zeng F, Deng G, Cui Y, Zhang Y, Dai M, Chen L, et al. A predictive model for the severity of COVID-19 in elderly patients. Aging (Albany NY). 2020; 12(21): 20982-96. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Dong Y, Zhou H, Li M, Zhang Z, Guo W, Yu T, et al. A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection. Transbound Emerg Dis. 2020;67(6):2823-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Badal S, Thapa Bajgain K, Badal S, Thapa R, Bajgain BB, Santana MJ. Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis. J Clin Virol. 2021;135:104715. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Castro VM, McCoy TH, Perlis RH. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts. JAMA Netw Open. 2020;3(10):e2023934. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Bertsimas D, Lukin G, Mingardi L, Nohadani O, Orfanoudaki A, Stellato B, et al. COVID-19 Study Group. COVID-19 mortality risk assessment: An international multi-center study. PLoS One. 2020;15(12):e0243262. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Tang Y-W, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. Journal of clinical microbiology. 2020;58(6). [View at Publisher] [DOI] [PMID] [Google Scholar]
27. R Core Team. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria. 2020. [View at Publisher] [Google Scholar]
28. Kleinbaum DG, Klein M. Survival analysis. 3rd ed.Vol3. New York:Springer;2010. [View at Publisher] [Google Scholar] [View at Publisher] [Google Scholar]
29. Kassambara A, Kosinski M, Biecek P, Fabian S. Package 'survminer'. Drawing Survival Curves using 'ggplot2'(R package version 03 1). 2017. [View at Publisher] [Google Scholar] [View at Publisher] [Google Scholar]
30. Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox's proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1-13. [View at Publisher] [DOI:10.18637/jss.v039.i05] [PMID] [Google Scholar]
31. Rondeau V, Mazroui Y, Gonzalez JR. frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation. J Stat Softw. 2012;47(4):1-28. [View at Publisher] [DOI] [Google Scholar]
32. Song Xiao, and Xiao-Hua Zhou. A semiparametric approach for the covariate specific ROC curve with survival outcome. Statistica Sinica. 2008;18(3):947-65. [View at Publisher] [Google Scholar]
33. Schmid M, Potapov S, Adler W. survAUC: Estimators of Prediction Accuracy for Time-to-Event Data. The R User Conference, useR! UK: University of Warwick, Coventry;2011. [View at Publisher] [Google Scholar]
34. Assaf S, Campostrini S. Application of the varying coefficient model to the behaviour risk factor surveillance data in Italy: a study of changing smoking prevalence among sub-populations. BMC Public Health. 2015;15(1):489. [View at Publisher] [Google Scholar] [DOI] [PMID] [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Wood SN. Generalized additive models: an introduction with R. 2nd ed. Boca Raton:CRC press;2017. 496p. [View at Publisher] [Google Scholar] [DOI] [View at Publisher] [Google Scholar]
36. Ataei N, Hosseini M, Fayaz M, Navidi I, Taghiloo A, Kalantari K, et al. Blood pressure percentiles by age and height for children and adolescents in Tehran, Iran. J Hum hypertens. 2016;30(4):268-77. [View at Publisher] [DOI] [PMID] [Google Scholar]
37. Park SH, Park CJ, Lee BR, Kim MJ, Han MY, Cho YU, et al. Establishment of age-and gender-specific reference ranges for 36 routine and 57 cell population data items in a new automated blood cell analyzer, Sysmex XN-2000. Ann Lab Med. 2016;36(3):244-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
38. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. [View at Publisher] [Google Scholar]
39. Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on Kidney Dysfunctions of COVID-19 Patients. medRxiv. PPR:PPR112604. [View at Publisher] [DOI] [View at Publisher]
40. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. [View at Publisher] [DOI] [PMID] [Google Scholar]
41. Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93(2):786-93. [View at Publisher] [DOI] [PMID] [Google Scholar]
42. Cheng A, Hu L, Wang Y, Huang L, Zhao L, Zhang C, et al. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents. 2020;56(3):106110. [View at Publisher] [Google Scholar] [DOI] [PMID] [View at Publisher] [DOI] [PMID] [Google Scholar]
43. Wernly B, Lichtenauer M, Vellinga NAR, Boerma EC, Ince C, Kelm M, et al. Blood urea nitrogen (BUN) independently predicts mortality in critically ill patients admitted to ICU: A multicenter study. Clin Hemorheol Microcirc. 2018;69(1-2):123-31. [View at Publisher] [DOI] [PMID] [Google Scholar]
44. Arihan O, Wernly B, Lichtenauer M, Franz M, Kabisch B, Muessig J, et al. Blood urea nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU. PLoS One. 2018;13(1):e0191697. [View at Publisher] [DOI] [PMID] [Google Scholar]
45. Miura M, Sakata Y, Nochioka K, Takahashi J, Takada T, Miyata S, et al. Prognostic impact of blood urea nitrogen changes during hospitalization in patients with acute heart failure syndrome. Circ J. 2013;77(5):1221-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
46. Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney Int. 2018;93(3):741-52. [View at Publisher] [DOI] [PMID] [Google Scholar]
47. Wu KH, Shih HA, Hung MS, Hsiao CT, Chen YC. The association between blood urea nitrogen to creatinine ratio and mortality in patients with upper gastrointestinal bleeding. Arab J Gastroenterol. 2018;19(4):143-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
48. Lin S, Hong W, Basharat Z, Wang Q, Pan J, Zhou M. Blood Urea Nitrogen as a Predictor of Severe Acute Pancreatitis Based on the Revised Atlanta Criteria: Timing of Measurement and Cutoff Points. Can J Gastroenterol Hepatol. 2017;2017:9592831. [View at Publisher] [DOI] [PMID] [Google Scholar]
49. Tatlisu MA, Kaya A, Keskin M, Avsar S, Bozbay M, Tatlisu K, et al. The association of blood urea nitrogen levels with mortality in acute pulmonary embolism. J Crit Care. 2017;39:248-53. [View at Publisher] [DOI] [PMID] [Google Scholar]
50. Kazory A . Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol. 2010;106(5):694-700. [View at Publisher] [DOI] [PMID] [Google Scholar]
51. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116(7):466-73. [View at Publisher] [DOI] [PMID] [Google Scholar]
52. Feng DY, Zhou YQ, Zou XL, Zhou M, Yang HL, Chen XX, et al. Elevated blood urea nitrogen-to-serum albumin ratio as a factor that negatively affects the mortality of patients with hospital-acquired pneumonia. Can J Infect Dis Med Microbiol. 2019;2019:1547405. [View at Publisher] [DOI] [PMID] [Google Scholar]
53. Tokgoz Akyil F, Yalcinsoy M, Hazar A , Cilli A , Celenk B, Kilic O, et al. Prognosis of hospitalized patients with community-acquired pneumonia. Pulmonology. 2018;24(3):164-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [View at Publisher] [DOI] [PMID] [Google Scholar]
54. Ryu S, Oh SK, Cho SU, You Y, Park JS, Min JH, et al. Utility of the blood urea nitrogen to serum albumin ratio as a prognostic factor of mortality in aspiration pneumonia patients. Am J Emerg Med. 2021;43:175-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
55. Yang CJ, Chen J, Phillips AR, Windsor JA, Petrov MS. Predictors of severe and critical acute pancreatitis: a systematic review. Dig Liver Dis. 2014;46(5):446-51. [View at Publisher] [DOI] [PMID] [Google Scholar]
56. Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157-65. [View at Publisher] [DOI] [PMID] [Google Scholar]
57. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
58. Oudit GY, Pfeffer MA. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19. Eur Heart J. 2020;41(19):1818-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
59. Ren D, Ren C, Yao RQ, Feng YW, Yao YM. Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China. Intensive Care Med. 2020;46(8):1630-3. [View at Publisher] [DOI] [PMID] [Google Scholar]
60. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738-42. [View at Publisher] [DOI] [PMID] [Google Scholar]
61. Thum T. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure? Eur Heart J. 2020;41(19):1807-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
62. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized with COVID-19. Circ Res. 2020;126(12):1671-81. [View at Publisher] [DOI] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.